פרטים כלליים
שם
Name
ציפרודקס 500
CIPRODEX 500
יצרן
DEXCEL LTD, ISRAEL
בעל רישום
DEXCEL LTD, ISRAEL
שימוש
צורת מינון
Dosage Form
קפליות
CAPLETS
דרך מתן
Usage Form
פומי
PER OS
תמונה חסרה
מחירים לצרכן
לא נמצא מידע
חומר פעיל
חומר פעיל
כמות
500 MG
תרופות אחרות בעלות אותם מרכיבים
ATC
עדכון רישום
סוג עדכון
תאריך עדכון
30.09.2024
30.09.2024
29.02.2024
29.02.2024
15.09.2021
15.09.2021
15.09.2021
15.09.2021
31.01.2020
31.01.2020
30.01.2020
30.01.2020
06.05.2019
06.05.2019
06.05.2019
06.05.2019
26.02.2019
26.02.2019
05.03.2017
05.03.2017
התוויה מאושרת
CIPRODEX caplets are indicated for the treatment of the following infections:Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Adults • Lower respiratory tract infections due to Gram-negative bacteria - exacerbations of chronic obstructive pulmonary disease o In exacerbation of chronic obstructive pulmonary disease CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis - pneumonia • Chronic suppurative otitis media • Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria • Uncomplicated acute cystitis - In uncomplicated acute cystitis CIPRODEX should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. • Acute pyelonephritis • Complicated urinary tract infections • Bacterial prostatitis • Genital tract infections - gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae - epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae - pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae • Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea) • Intra-abdominal infections • Infections of the skin and soft tissue caused by Gram-negative bacteria • Malignant external otitis • Infections of the bones and joints • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Children and adolescents • Broncho-pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis • Complicated urinary tract infections and acute pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary. Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.
בסל הבריאות
כן
מספר רישום
123-60-30428-00
תנאי ניפוק
תרופה במרשם
מגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת